Takashi Ishikawa

14.0k citations
440 papers · 8.3k indexed · 2 hit papers · h-index 44

Takashi Ishikawa

413 papers receiving 8.1k citations

Hit Papers

Five-year survival analysis of surgi...3632005202620122019200400600

Peers

Takashi Ishikawa
Comparison fields: 5 of 158
  • Hepatology 1.1k
  • Cancer Research 1.5k
  • Gastroenterology 451
  • Oncology 2.1k
  • Nuclear and High Energy Physics 649
Replace Junji Tanaka with:
Junji Tanaka Japan
Takeharu Yamanaka Japan
Yasuhiro Miyake Japan
Koichi Matsuda Japan
Henk M.W. Verheul Netherlands
George A. Fisher United States
Julien Taı̈eb France
Wenbiao Liu China
Tohru Takahashi Japan
Mikio Namiki Japan
Takashi Ishikawa relative to Junji Tanaka Japan Junji Tanaka's profile →
Citations per field
00.5×
Junji Tanaka · 1×
Citations per year

Countries citing papers authored by Takashi Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Takashi Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Ishikawa more than expected).

Fields of papers citing papers by Takashi Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Ishikawa. The network helps show where Takashi Ishikawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Takashi Ishikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Takashi Ishikawa Line = papers co-authored together Takashi Ishikawa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20241
4 20241
5 20241
6 20232
7 20239
8 20236
9 20231
10 20233
11 20231
12 20233
13 20224
14 20212
15 20215
16 202015
17 202018
18 201861
19 199917
20 19943

About Takashi Ishikawa

Takashi Ishikawa is a scholar working on Gastroenterology, Cancer Research and Oncology, having authored 440 papers that have together received 8.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (45 papers), Breast Cancer Treatment Studies (44 papers), Gastrointestinal Tumor Research and Treatment (35 papers), HER2/EGFR in Cancer Research (29 papers), Atomic and Molecular Physics (26 papers), Breast Implant and Reconstruction (25 papers), Cancer Treatment and Pharmacology (24 papers) and Advanced Chemical Physics Studies (22 papers). The work is most often cited by research in Hepatology (1.1k citations), Cancer Research (1.5k citations) and Gastroenterology (451 citations). Takashi Ishikawa has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Kazuaki Takabe, Yasushi Ichikawa, Mariko Asaoka, Itaru Endo, R. Hayano, Hiroshi Shimada, Masanori Oshi, Masao Omata, Shuntaro Obi and Shuichiro Shiina. Their work appears in journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026